Mark Hamner to Depressive Disorder, Major
This is a "connection" page, showing publications Mark Hamner has written about Depressive Disorder, Major.
Connection Strength
0.256
-
Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022 07 12; 328(2):151-161.
Score: 0.145
-
Recurrent psychotic depression associated with GM2 gangliosidosis. Psychosomatics. 1998 Sep-Oct; 39(5):446-8.
Score: 0.111